ES2194834T3 - Transformacion por medio de particulas de celulas somaticas animales. - Google Patents

Transformacion por medio de particulas de celulas somaticas animales.

Info

Publication number
ES2194834T3
ES2194834T3 ES90910074T ES90910074T ES2194834T3 ES 2194834 T3 ES2194834 T3 ES 2194834T3 ES 90910074 T ES90910074 T ES 90910074T ES 90910074 T ES90910074 T ES 90910074T ES 2194834 T3 ES2194834 T3 ES 2194834T3
Authority
ES
Spain
Prior art keywords
animals
transformation
somatic cell
spark discharge
cell particles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90910074T
Other languages
English (en)
Inventor
Winston J Brill
Dennis E Mccabe
Ning-Sun Yang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Powderject Vaccines Inc
Original Assignee
Powderject Vaccines Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27005554&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2194834(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Powderject Vaccines Inc filed Critical Powderject Vaccines Inc
Application granted granted Critical
Publication of ES2194834T3 publication Critical patent/ES2194834T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M35/00—Means for application of stress for stimulating the growth of microorganisms or the generation of fermentation or metabolic products; Means for electroporation or cell fusion
    • C12M35/02—Electrical or electromagnetic means, e.g. for electroporation or for cell fusion
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/89—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microinjection
    • C12N15/895—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microinjection using biolistic methods

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Sustainable Development (AREA)
  • Electromagnetism (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicinal Preparation (AREA)

Abstract

SE DESCUBRE UN METODO PARA LA TRANSFORMACION CONVENIENTE DE LAS CELULAS SOMATICAS DE ANIMALES. LA TRANSFORMACION DE CELULAS SOMATICAS ES UTIL PARA EL CUIDADO MEDICO Y VETERINARIO DE ENFERMEDADES GENETICAS, Y PARA OTROS PROPOSITOS TERAPEUTICOS O DE MEJORAMIENTO DE ANIMALES. EL METODO UTILIZA UN APARATO ELECTRICO DE ACELERACION DE DESCARGA DE PARTICULAS QUE PUEDE INYECTAR UNAS PARTICULAS MUY PEQUEÑAS DE ORO Y OTRO MATERIAL DENSO LLEVANDO CONSTRUCTORES GENETICOS REVESTIDOS EN EL A LAS CELULAS VIVAS DE ANIMALES. LOS ANIMALES NO SOLO VIVEN, SI NO QUE NO HAY NINGUN ROCE NI SANGRE EN EL LUGAR DEL TRATAMIENTO. EL METODO ES PARCICULARMENTE ADAPTABLE DESDE QUE LA FUERZA DE LA INYECCION DE PARTICULAS EN TAL APARATO DE DESCARGA DE CHISPAS ES AJUSTABLE MEDIANTE AJUSTES A LA TENSION DE LA DESCARGA DE CHISPAS.
ES90910074T 1989-06-26 1990-06-21 Transformacion por medio de particulas de celulas somaticas animales. Expired - Lifetime ES2194834T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37186989A 1989-06-26 1989-06-26
US49493390A 1990-03-14 1990-03-14

Publications (1)

Publication Number Publication Date
ES2194834T3 true ES2194834T3 (es) 2003-12-01

Family

ID=27005554

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90910074T Expired - Lifetime ES2194834T3 (es) 1989-06-26 1990-06-21 Transformacion por medio de particulas de celulas somaticas animales.

Country Status (10)

Country Link
US (2) US20020081739A1 (es)
EP (1) EP0431135B1 (es)
JP (2) JP3573454B2 (es)
AT (1) ATE235558T1 (es)
AU (2) AU5856790A (es)
CA (1) CA2019676C (es)
DE (1) DE69034053T2 (es)
DK (1) DK0431135T3 (es)
ES (1) ES2194834T3 (es)
WO (1) WO1991000359A1 (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991007487A1 (en) 1989-11-16 1991-05-30 Duke University Particle-mediated transformation of animal tissue cells
US5149655A (en) * 1990-06-21 1992-09-22 Agracetus, Inc. Apparatus for genetic transformation
AU1663392A (en) * 1991-03-06 1992-10-06 Agracetus, Inc. Particle mediated transformation of cotton
CA2098498A1 (en) * 1991-10-15 1993-04-16 Ning-Sun Yang Particle-mediated transformation of mammalian unattached cells
WO1993008292A1 (en) * 1991-10-16 1993-04-29 Agracetus, Inc. Particle-mediated transformation of animal somatic cells
US5260191A (en) * 1992-01-30 1993-11-09 Agracetus, Inc. Method for diagnosing tumors
EP0584339A4 (en) * 1992-03-04 1996-02-28 Jon A Wolff Method of delivering therapeutic substances to the brain
DE69333814T2 (de) * 1992-03-11 2006-02-02 Powderject Vaccines, Inc., Madison Genetischer impfstoff gegen den immunschwäche virus
AU2146092A (en) * 1992-05-28 1993-12-30 Scientific Dimensions Usa, Inc. Transgenic animal production with biolistically transformed spermatozoa
AU7102194A (en) * 1993-06-30 1995-01-24 Dcv Biologics L.P. A method for introducing a biological substance into a target
GB2282139A (en) * 1993-09-24 1995-03-29 Univ Reading Introducing DNA into the germ line of birds
US6995008B1 (en) 1994-03-07 2006-02-07 Merck & Co., Inc. Coordinate in vivo gene expression
US7223739B1 (en) 1995-06-07 2007-05-29 Powderject Vaccines, Inc. Adjuvanted genetic vaccines
CA2216308A1 (en) * 1995-12-21 1997-07-03 Solvay (Societe Anonyme) Plasmid vaccine for pseudorabies virus
BE1010344A3 (fr) * 1996-06-12 1998-06-02 Solvay Vaccin plasmidique contre le virus pseudorabique.
US6693087B1 (en) 1998-08-20 2004-02-17 Aventis Pasteur Limited Nucleic acid molecules encoding POMP91A protein of Chlamydia
CA2340330A1 (en) 1998-08-20 2000-03-02 Aventis Pasteur Limited Nucleic acid molecules encoding inclusion membrane protein c of chlamydia
US6686339B1 (en) 1998-08-20 2004-02-03 Aventis Pasteur Limited Nucleic acid molecules encoding inclusion membrane protein C of Chlamydia
US6881723B1 (en) 1998-11-05 2005-04-19 Powderject Vaccines, Inc. Nucleic acid constructs
AU3593200A (en) 1999-02-09 2000-08-29 Powderject Vaccines, Inc. (mycobacterium tuberculosis), immunization
US7196066B1 (en) 1999-11-03 2007-03-27 Powderject Vaccines, Inc. DNA-vaccines based on constructs derived from the genomes of human and animal pathogens
EP1792995A3 (en) 2000-05-08 2007-06-13 Sanofi Pasteur Limited Chlamydia secretory locus orf and uses thereof
AU5810201A (en) 2000-05-10 2001-11-20 Aventis Pasteur Immunogenic polypeptides encoded by mage minigenes and uses thereof
GB0201736D0 (en) * 2002-01-25 2002-03-13 Glaxo Group Ltd DNA dosage forms
ES2285087T3 (es) * 2002-01-25 2007-11-16 Glaxo Group Limited Formas farmaceuticas de adn.
EP1356820A1 (en) 2002-04-26 2003-10-29 Institut National De La Sante Et De La Recherche Medicale (Inserm) DNA vaccine combined with an inducer of tumor cell apoptosis
US9029135B2 (en) 2009-03-27 2015-05-12 Institut National De La Sante Et De La Recherche Medicale (Inserm) Kanamycin antisense nucleic acid for the treatment of cancer
CA2798837A1 (en) 2010-06-07 2011-12-15 Pfizer Inc. Her-2 peptides and vaccines
CN113260697A (zh) 2018-12-20 2021-08-13 国立大学法人丰桥技术科学大学 电穿孔装置以及外来物质导入细胞的制造方法
IT201900007060A1 (it) 2019-05-21 2020-11-21 St Superiore Di Sanita Cellule tumorali ingegnerizzate e loro usi
IT201900012540A1 (it) 2019-07-22 2021-01-22 Humanitas Mirasole Spa Inibitori di CHI3L1 e loro usi
EP4200452A1 (en) 2020-08-18 2023-06-28 Enviro Metals, LLC Metal refinement

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4945050A (en) * 1984-11-13 1990-07-31 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
IL84459A (en) * 1986-12-05 1993-07-08 Agracetus Apparatus and method for the injection of carrier particles carrying genetic material into living cells
US5015580A (en) * 1987-07-29 1991-05-14 Agracetus Particle-mediated transformation of soybean plants and lines
US5149655A (en) * 1990-06-21 1992-09-22 Agracetus, Inc. Apparatus for genetic transformation
US5405779A (en) * 1993-04-09 1995-04-11 Agracetus, Inc. Apparatus for genetic transformation
US5506125A (en) * 1993-12-22 1996-04-09 Agracetus, Inc. Gene delivery instrument with replaceable cartridges

Also Published As

Publication number Publication date
AU679477B2 (en) 1997-07-03
JP3573454B2 (ja) 2004-10-06
AU5787394A (en) 1994-05-19
EP0431135A1 (en) 1991-06-12
DK0431135T3 (da) 2003-07-21
AU5856790A (en) 1991-01-17
JP2001213807A (ja) 2001-08-07
CA2019676C (en) 2005-08-09
DE69034053T2 (de) 2003-12-04
US20020081739A1 (en) 2002-06-27
JPH04500314A (ja) 1992-01-23
WO1991000359A1 (en) 1991-01-10
ATE235558T1 (de) 2003-04-15
EP0431135B1 (en) 2003-03-26
DE69034053D1 (de) 2003-04-30
CA2019676A1 (en) 1990-12-26
US20050216959A1 (en) 2005-09-29

Similar Documents

Publication Publication Date Title
ES2194834T3 (es) Transformacion por medio de particulas de celulas somaticas animales.
BRPI0411817A (pt) aparelho e método para estimulação bioelétrica, aceleração da cura, alìvio da dor ou desvitalização de patógenos
ATE192500T1 (de) Rekombinante viren vektoren zur expression in muskelzellen
ATE179339T1 (de) Elektrische stimulierung zur behandlung von inkontinenz und anderen neuromuskularerkrankungen
DE69022290D1 (de) Lebende Impfstoffe.
ATE286118T1 (de) Anwendungen für humane nicht autologe, mesenchymale stammzellen
IL78553A (en) Therapeutic compositions of phosphonylmethoxyalkyl adenines
DE69733205D1 (de) Vorrichtung zur behandlung von tumor-erkrankungen ( krebsleiden )
GEP20002180B (en) Composition and Methods for Stimulating Megakaryocyte Growth and Differentiation
SE8704458L (sv) Elektrodanordning foer infoerande i ett levande vaesens kropp
DE3876756D1 (de) Vorrichtung zur gesteuerten freigabe und verabreichung von wirkstoffen an tierisches gewebe.
ATE133859T1 (de) Pharmazeutische zubereitungen mit verzögerter freisetzung zur behandlung periodontaler erkrankungen
Pettigrew et al. A tactile fovea in the Scolopacidae?
DE69833876D1 (de) Zusammensetzungen und methoden zur zielgerichteten abgabe von biologisch aktivenfaktoren
Giszter et al. Trunk sensorimotor cortex is essential for autonomous weight-supported locomotion in adult rats spinalized as P1/P2 neonates
WARD Tegmental self-stimulation after amygdaloid ablation: Results of studies in rats
Erndt-Marino et al. Membrane potential controls macrophage activation
CN111172151A (zh) 一种电信号通过调节皮肤DCs/LCs提呈至T细胞而调控机体免疫反应的方法及其用途
GEP20012489B (en) Use of Natural Human α-Interferon
Farsani et al. Gene therapy a new approach in dentistry: human or microbial gene modification
KR910004802A (ko) 긴팔원숭이 백혈병 비루스 리셉터 단백질, 이를 암호화하는 단리된 정제 dna 서열 및 이들을 동정하는 방법
SU1713600A1 (ru) Способ лечени диспепсии жвачных животных
ES8200920A1 (es) Procedimiento de preparacion de una nueva substancia a par- tir de celulas aisladas del cultivo de micrococcus sedogen- tes m 78
Kotnik et al. Potential therapeutic indications for synthetic desmuramyl MDP analogue (LK-409)
Crookes On Metallic Colloids and Their Bactericidal Properties